Showing results (21-30 of 214) with videos related to
Sort By:
Pageof 22
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Risk of breast cancer during hormone replacement therapy: mechanismsAlfred O Mueck, Harald Seeger, Samuel ShapiroMenopause (New York, N.Y.)|June 26, 2002
Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell culturesAlfred O Mueck, Harald Seeger, Diethelm WallwienerMaturitas|February 28, 2012
The pharmacology of nomegestrol acetateXiangyan Ruan, Harald Seeger, Alfred O MueckMaturitas|October 20, 2009
Use of dydrogesterone in hormone replacement therapyAlfred O Mueck, Harald Seeger, Kai-J BühlingGynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 13, 2009
Why use of dienogest for the first contraceptive pill with estradiol?Alfred O Mueck, Harald Seeger, Kai J BühlingMaturitas|September 25, 2002
Estradiol metabolism and malignant diseaseAlfred O Mueck, Harald Seeger, Theodor H LippertMaturitas|October 11, 2005
Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cellsHarald Seeger, Diethelm Wallwiener, Elizabeth Kraemer, et al.Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Effect of drospirenone on proliferation of human benign and cancerous epithelial breast cellsHarald Seeger, Xiangjan Ruan, Hans Neubauer, et al.Maturitas|October 19, 2004
Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferationHarald Seeger, Fritz-Ulrich Deuringer, Diethelm Wallwiener, et al.Hormone Research|December 4, 2003
Effects of oxytocin outside pregnancyTheodor H Lippert, Alfred O Mueck, Harald Seeger, et al.Pageof 22